Macular Disease Foundation Australia (MDFA) has had an undertaking by both major political parties that they won’t implement an MBS Review Taskforce proposal to cut the intravitreal injection rebate by 69%, in a major win for the eye health sector. Read more
Both sides of the political divide are promising to slash the maximum price Australians pay for a PBS script, if elected to govern at the 21 May election, in a move set to benefit thousands of patients with eye disease. Read more
RANZCO has appointed experience medical organisation executive, Mr Mark Carmichael, as its next CEO to replace Dr David Andrews. Read more
Specsavers has been crowned one of Australia’s most-trusted optometry brands, as judged by Reader’s Digest Magazine’s annual consumer survey, while also being recognised in the Contact Lens Solution and Hearing Services categories. Read more
The Australian College of Optometry (ACO) is joining Optometry Australia (OA)’s call for a $1 million investment into a collaborative eyecare pilot to reduce ‘drop out’ from routine intravitreal injections. Read more
Tokai Optical has launched a unique material designed by its in-house R&D team – and available across most of its products – to protect lutein, one of two major carotenoids found in the human eye. Read more
A pioneering study out of Western Australia has shown that a longer acting intravitreal dexamethasone implant (DEX-implant) may lead to better outcomes in some Aboriginal patients with diabetic macular oedema (DMO) compared with the standard of care, anti-VEGF injections. Read more
Described as a mentor and pioneer, South Australian optometrist Mr Ronald Fieldhouse passed away on April 13, aged 97. Read more
The Therapeutic Goods Administration (TGA) has approved a new AI software system that can screen for three major eye diseases in primary care settings. Read more
Registrations are now open for Optometry Australia (OA)’s annual national conference and product showcase, Optometry Virtually Connected.